NAV — Navco Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- CA$1.43m
- CA$1.51m
Annual cashflow statement for Navco Pharmaceuticals, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2022 June 30th | 2023 September 30th | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -0.094 | -2.15 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | — | 0.947 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 0.083 | -0.62 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Cash from Operating Activities | -0.01 | -1.78 |
| Financing Cash Flow Items | — | -0.029 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 0 | 2.01 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -0.01 | 0.233 |